Researchers may use the model to further study whether anti-HSV-1 treatment blocks the disease consequences related to AD, including Aβ accumulation, tau hyperphosphorylation, neuroinflammation (astrogliosis and inflammatory cytokines/chemokines secretion), and/or cognitive deficits through measurable behavior testing. The gene discussed is MAPT; the disease is Alzheimer disease.